nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.114	0.17	CbGbCtD
Hydrocodone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.114	0.17	CbGbCtD
Hydrocodone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.101	0.152	CbGbCtD
Hydrocodone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0953	0.143	CbGbCtD
Hydrocodone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0644	0.0966	CbGbCtD
Hydrocodone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0614	0.0921	CbGbCtD
Hydrocodone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0548	0.0821	CbGbCtD
Hydrocodone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0321	0.0482	CbGbCtD
Hydrocodone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0303	0.0455	CbGbCtD
Hydrocodone—Galantamine—CHRNA5—chronic obstructive pulmonary disease	0.0049	0.376	CrCbGaD
Hydrocodone—Naloxone—TLR4—chronic obstructive pulmonary disease	0.0032	0.245	CrCbGaD
Hydrocodone—Galantamine—CHRNA3—chronic obstructive pulmonary disease	0.00229	0.176	CrCbGaD
Hydrocodone—Dextromethorphan—CHRNA3—chronic obstructive pulmonary disease	0.00172	0.132	CrCbGaD
Hydrocodone—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.00473	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.00134	0.0047	CcSEcCtD
Hydrocodone—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00464	CcSEcCtD
Hydrocodone—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00461	CcSEcCtD
Hydrocodone—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.0013	0.00457	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00453	CcSEcCtD
Hydrocodone—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00128	0.0045	CcSEcCtD
Hydrocodone—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00128	0.00448	CcSEcCtD
Hydrocodone—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00127	0.00447	CcSEcCtD
Hydrocodone—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.00127	0.00447	CcSEcCtD
Hydrocodone—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00445	CcSEcCtD
Hydrocodone—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00442	CcSEcCtD
Hydrocodone—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00434	CcSEcCtD
Hydrocodone—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00431	CcSEcCtD
Hydrocodone—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00121	0.00426	CcSEcCtD
Hydrocodone—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00422	CcSEcCtD
Hydrocodone—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00415	CcSEcCtD
Hydrocodone—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.00409	CcSEcCtD
Hydrocodone—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00407	CcSEcCtD
Hydrocodone—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00407	CcSEcCtD
Hydrocodone—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00406	CcSEcCtD
Hydrocodone—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00406	CcSEcCtD
Hydrocodone—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00114	0.00401	CcSEcCtD
Hydrocodone—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00397	CcSEcCtD
Hydrocodone—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00111	0.00389	CcSEcCtD
Hydrocodone—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00383	CcSEcCtD
Hydrocodone—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.00382	CcSEcCtD
Hydrocodone—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00379	CcSEcCtD
Hydrocodone—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00379	CcSEcCtD
Hydrocodone—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00378	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00377	CcSEcCtD
Hydrocodone—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00372	CcSEcCtD
Hydrocodone—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00372	CcSEcCtD
Hydrocodone—Contusion—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00371	CcSEcCtD
Hydrocodone—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00371	CcSEcCtD
Hydrocodone—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.00367	CcSEcCtD
Hydrocodone—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00364	CcSEcCtD
Hydrocodone—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.00364	CcSEcCtD
Hydrocodone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.00364	CcSEcCtD
Hydrocodone—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.00362	CcSEcCtD
Hydrocodone—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00362	CcSEcCtD
Hydrocodone—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00362	CcSEcCtD
Hydrocodone—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00103	0.0036	CcSEcCtD
Hydrocodone—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00359	CcSEcCtD
Hydrocodone—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00359	CcSEcCtD
Hydrocodone—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00356	CcSEcCtD
Hydrocodone—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00354	CcSEcCtD
Hydrocodone—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00354	CcSEcCtD
Hydrocodone—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.00353	CcSEcCtD
Hydrocodone—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00351	CcSEcCtD
Hydrocodone—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000993	0.00349	CcSEcCtD
Hydrocodone—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000991	0.00348	CcSEcCtD
Hydrocodone—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000991	0.00348	CcSEcCtD
Hydrocodone—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000985	0.00346	CcSEcCtD
Hydrocodone—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000985	0.00346	CcSEcCtD
Hydrocodone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000978	0.00343	CcSEcCtD
Hydrocodone—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000973	0.00342	CcSEcCtD
Hydrocodone—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000967	0.00339	CcSEcCtD
Hydrocodone—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000965	0.00338	CcSEcCtD
Hydrocodone—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00096	0.00337	CcSEcCtD
Hydrocodone—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00096	0.00337	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000944	0.00331	CcSEcCtD
Hydrocodone—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00094	0.0033	CcSEcCtD
Hydrocodone—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000937	0.00329	CcSEcCtD
Hydrocodone—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000936	0.00328	CcSEcCtD
Hydrocodone—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00093	0.00326	CcSEcCtD
Hydrocodone—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00093	0.00326	CcSEcCtD
Hydrocodone—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000921	0.00323	CcSEcCtD
Hydrocodone—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000907	0.00318	CcSEcCtD
Hydrocodone—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000906	0.00318	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000898	0.00315	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000894	0.00314	CcSEcCtD
Hydrocodone—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000894	0.00314	CcSEcCtD
Hydrocodone—Cough—Formoterol—chronic obstructive pulmonary disease	0.000894	0.00314	CcSEcCtD
Hydrocodone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000886	0.00311	CcSEcCtD
Hydrocodone—Cough—Montelukast—chronic obstructive pulmonary disease	0.000875	0.00307	CcSEcCtD
Hydrocodone—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000873	0.00306	CcSEcCtD
Hydrocodone—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000872	0.00306	CcSEcCtD
Hydrocodone—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000872	0.00306	CcSEcCtD
Hydrocodone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000872	0.00306	CcSEcCtD
Hydrocodone—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000872	0.00306	CcSEcCtD
Hydrocodone—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000869	0.00305	CcSEcCtD
Hydrocodone—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000869	0.00305	CcSEcCtD
Hydrocodone—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000869	0.00305	CcSEcCtD
Hydrocodone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000868	0.00305	CcSEcCtD
Hydrocodone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000868	0.00305	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000866	0.00304	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000866	0.00304	CcSEcCtD
Hydrocodone—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000854	0.003	CcSEcCtD
Hydrocodone—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000854	0.003	CcSEcCtD
Hydrocodone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000853	0.00299	CcSEcCtD
Hydrocodone—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000853	0.00299	CcSEcCtD
Hydrocodone—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000851	0.00299	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000848	0.00298	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000847	0.00297	CcSEcCtD
Hydrocodone—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000844	0.00296	CcSEcCtD
Hydrocodone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000823	0.00289	CcSEcCtD
Hydrocodone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000823	0.00289	CcSEcCtD
Hydrocodone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000821	0.00288	CcSEcCtD
Hydrocodone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00082	0.00288	CcSEcCtD
Hydrocodone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00082	0.00288	CcSEcCtD
Hydrocodone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000819	0.00287	CcSEcCtD
Hydrocodone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000812	0.00285	CcSEcCtD
Hydrocodone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000812	0.00285	CcSEcCtD
Hydrocodone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000809	0.00284	CcSEcCtD
Hydrocodone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000805	0.00283	CcSEcCtD
Hydrocodone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000803	0.00282	CcSEcCtD
Hydrocodone—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000802	0.00281	CcSEcCtD
Hydrocodone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000795	0.00279	CcSEcCtD
Hydrocodone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000781	0.00274	CcSEcCtD
Hydrocodone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000781	0.00274	CcSEcCtD
Hydrocodone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000777	0.00273	CcSEcCtD
Hydrocodone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000774	0.00272	CcSEcCtD
Hydrocodone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000767	0.00269	CcSEcCtD
Hydrocodone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000763	0.00268	CcSEcCtD
Hydrocodone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000763	0.00268	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000762	0.00267	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000762	0.00267	CcSEcCtD
Hydrocodone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000756	0.00265	CcSEcCtD
Hydrocodone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000756	0.00265	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000746	0.00262	CcSEcCtD
Hydrocodone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000745	0.00262	CcSEcCtD
Hydrocodone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000745	0.00262	CcSEcCtD
Hydrocodone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000743	0.00261	CcSEcCtD
Hydrocodone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000743	0.00261	CcSEcCtD
Hydrocodone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000741	0.0026	CcSEcCtD
Hydrocodone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000738	0.00259	CcSEcCtD
Hydrocodone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000735	0.00258	CcSEcCtD
Hydrocodone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000733	0.00257	CcSEcCtD
Hydrocodone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000728	0.00255	CcSEcCtD
Hydrocodone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000726	0.00255	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000722	0.00253	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000722	0.00253	CcSEcCtD
Hydrocodone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000721	0.00253	CcSEcCtD
Hydrocodone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000721	0.00253	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000719	0.00252	CcSEcCtD
Hydrocodone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000715	0.00251	CcSEcCtD
Hydrocodone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000715	0.00251	CcSEcCtD
Hydrocodone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000714	0.00251	CcSEcCtD
Hydrocodone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000709	0.00249	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000707	0.00248	CcSEcCtD
Hydrocodone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000706	0.00248	CcSEcCtD
Hydrocodone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000704	0.00247	CcSEcCtD
Hydrocodone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000702	0.00246	CcSEcCtD
Hydrocodone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000698	0.00245	CcSEcCtD
Hydrocodone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000693	0.00243	CcSEcCtD
Hydrocodone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000692	0.00243	CcSEcCtD
Hydrocodone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000688	0.00241	CcSEcCtD
Hydrocodone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000685	0.0024	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000684	0.0024	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000684	0.0024	CcSEcCtD
Hydrocodone—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000683	0.0024	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00239	CcSEcCtD
Hydrocodone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00239	CcSEcCtD
Hydrocodone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.00237	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00067	0.00235	CcSEcCtD
Hydrocodone—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000669	0.00235	CcSEcCtD
Hydrocodone—OPRM1—Opioid Signalling—PDE4A—chronic obstructive pulmonary disease	0.000662	0.0189	CbGpPWpGaD
Hydrocodone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000661	0.00232	CcSEcCtD
Hydrocodone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000661	0.00232	CcSEcCtD
Hydrocodone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000661	0.00232	CcSEcCtD
Hydrocodone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000661	0.00232	CcSEcCtD
Hydrocodone—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000659	0.00231	CcSEcCtD
Hydrocodone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000659	0.00231	CcSEcCtD
Hydrocodone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000653	0.00229	CcSEcCtD
Hydrocodone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000653	0.00229	CcSEcCtD
Hydrocodone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000652	0.00229	CcSEcCtD
Hydrocodone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000649	0.00228	CcSEcCtD
Hydrocodone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000647	0.00227	CcSEcCtD
Hydrocodone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000647	0.00227	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000645	0.00226	CcSEcCtD
Hydrocodone—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000634	0.00222	CcSEcCtD
Hydrocodone—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000624	0.0178	CbGpPWpGaD
Hydrocodone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000624	0.00219	CcSEcCtD
Hydrocodone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000624	0.00219	CcSEcCtD
Hydrocodone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000616	0.00216	CcSEcCtD
Hydrocodone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000616	0.00216	CcSEcCtD
Hydrocodone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000615	0.00216	CcSEcCtD
Hydrocodone—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000609	0.00214	CcSEcCtD
Hydrocodone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000606	0.0173	CbGpPWpGaD
Hydrocodone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000603	0.00212	CcSEcCtD
Hydrocodone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0006	0.0021	CcSEcCtD
Hydrocodone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0006	0.0021	CcSEcCtD
Hydrocodone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000591	0.00208	CcSEcCtD
Hydrocodone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000591	0.00208	CcSEcCtD
Hydrocodone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000587	0.00206	CcSEcCtD
Hydrocodone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000582	0.00204	CcSEcCtD
Hydrocodone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000579	0.00203	CcSEcCtD
Hydrocodone—OPRM1—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.000574	0.0164	CbGpPWpGaD
Hydrocodone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000566	0.00199	CcSEcCtD
Hydrocodone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000558	0.00196	CcSEcCtD
Hydrocodone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000553	0.00194	CcSEcCtD
Hydrocodone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000553	0.00194	CcSEcCtD
Hydrocodone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000541	0.0019	CcSEcCtD
Hydrocodone—Dextromethorphan—SLC6A4—chronic obstructive pulmonary disease	0.000538	0.0412	CrCbGaD
Hydrocodone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000532	0.00187	CcSEcCtD
Hydrocodone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000532	0.00187	CcSEcCtD
Hydrocodone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000527	0.00185	CcSEcCtD
Hydrocodone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000527	0.00185	CcSEcCtD
Hydrocodone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000527	0.00185	CcSEcCtD
Hydrocodone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000527	0.00185	CcSEcCtD
Hydrocodone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000524	0.00184	CcSEcCtD
Hydrocodone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000524	0.00184	CcSEcCtD
Hydrocodone—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000522	0.0149	CbGpPWpGaD
Hydrocodone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000522	0.00183	CcSEcCtD
Hydrocodone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000521	0.00183	CcSEcCtD
Hydrocodone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000516	0.00181	CcSEcCtD
Hydrocodone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000516	0.00181	CcSEcCtD
Hydrocodone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000513	0.0018	CcSEcCtD
Hydrocodone—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000502	0.0143	CbGpPWpGaD
Hydrocodone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000502	0.00176	CcSEcCtD
Hydrocodone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000498	0.00175	CcSEcCtD
Hydrocodone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000497	0.00174	CcSEcCtD
Hydrocodone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000497	0.00174	CcSEcCtD
Hydrocodone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000497	0.00174	CcSEcCtD
Hydrocodone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.00174	CcSEcCtD
Hydrocodone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000486	0.00171	CcSEcCtD
Hydrocodone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000481	0.00169	CcSEcCtD
Hydrocodone—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00047	0.0134	CbGpPWpGaD
Hydrocodone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000469	0.00165	CcSEcCtD
Hydrocodone—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000455	0.0016	CcSEcCtD
Hydrocodone—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000454	0.013	CbGpPWpGaD
Hydrocodone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000438	0.00154	CcSEcCtD
Hydrocodone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00042	0.00147	CcSEcCtD
Hydrocodone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000409	0.00144	CcSEcCtD
Hydrocodone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000408	0.0117	CbGpPWpGaD
Hydrocodone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000407	0.00143	CcSEcCtD
Hydrocodone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000406	0.00142	CcSEcCtD
Hydrocodone—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000403	0.00141	CcSEcCtD
Hydrocodone—OPRM1—TCR Signaling Pathway—IL17A—chronic obstructive pulmonary disease	0.0004	0.0114	CbGpPWpGaD
Hydrocodone—Naloxone—ALB—chronic obstructive pulmonary disease	0.000399	0.0306	CrCbGaD
Hydrocodone—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000388	0.0111	CbGpPWpGaD
Hydrocodone—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000379	0.0108	CbGpPWpGaD
Hydrocodone—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000371	0.0106	CbGpPWpGaD
Hydrocodone—OPRM1—IL4-mediated signaling events—IL10—chronic obstructive pulmonary disease	0.000366	0.0105	CbGpPWpGaD
Hydrocodone—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000365	0.0104	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.000364	0.0104	CbGpPWpGaD
Hydrocodone—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000356	0.0102	CbGpPWpGaD
Hydrocodone—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00123	CcSEcCtD
Hydrocodone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000343	0.0012	CcSEcCtD
Hydrocodone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000343	0.0012	CcSEcCtD
Hydrocodone—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000342	0.0012	CcSEcCtD
Hydrocodone—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000341	0.00976	CbGpPWpGaD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000341	0.0012	CcSEcCtD
Hydrocodone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.00117	CcSEcCtD
Hydrocodone—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000328	0.00938	CbGpPWpGaD
Hydrocodone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000323	0.00113	CcSEcCtD
Hydrocodone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00032	0.00112	CcSEcCtD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.000319	0.00912	CbGpPWpGaD
Hydrocodone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000318	0.00112	CcSEcCtD
Hydrocodone—OPRD1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000307	0.00878	CbGpPWpGaD
Hydrocodone—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000301	0.00859	CbGpPWpGaD
Hydrocodone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.0003	0.00105	CcSEcCtD
Hydrocodone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000299	0.00105	CcSEcCtD
Hydrocodone—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000298	0.00104	CcSEcCtD
Hydrocodone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000297	0.00847	CbGpPWpGaD
Hydrocodone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000295	0.00104	CcSEcCtD
Hydrocodone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000285	0.001	CcSEcCtD
Hydrocodone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000285	0.001	CcSEcCtD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000285	0.00814	CbGpPWpGaD
Hydrocodone—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000285	0.00813	CbGpPWpGaD
Hydrocodone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000284	0.000995	CcSEcCtD
Hydrocodone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000284	0.000995	CcSEcCtD
Hydrocodone—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000282	0.00805	CbGpPWpGaD
Hydrocodone—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000281	0.000987	CcSEcCtD
Hydrocodone—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00027	0.00771	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00027	0.00771	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000269	0.0077	CbGpPWpGaD
Hydrocodone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000944	CcSEcCtD
Hydrocodone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000269	0.000944	CcSEcCtD
Hydrocodone—OPRM1—TCR Signaling Pathway—CD8A—chronic obstructive pulmonary disease	0.000269	0.00768	CbGpPWpGaD
Hydrocodone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00026	0.000913	CcSEcCtD
Hydrocodone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00026	0.000913	CcSEcCtD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00025	0.00714	CbGpPWpGaD
Hydrocodone—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000248	0.00709	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000244	0.00698	CbGpPWpGaD
Hydrocodone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000242	0.00085	CcSEcCtD
Hydrocodone—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000239	0.00682	CbGpPWpGaD
Hydrocodone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000236	0.000828	CcSEcCtD
Hydrocodone—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000817	CcSEcCtD
Hydrocodone—OPRM1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000228	0.0065	CbGpPWpGaD
Hydrocodone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000223	0.00638	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000222	0.00634	CbGpPWpGaD
Hydrocodone—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000763	CcSEcCtD
Hydrocodone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.0062	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000214	0.00612	CbGpPWpGaD
Hydrocodone—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000214	0.00611	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000211	0.00604	CbGpPWpGaD
Hydrocodone—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000734	CcSEcCtD
Hydrocodone—Rash—Prednisone—chronic obstructive pulmonary disease	0.000207	0.000728	CcSEcCtD
Hydrocodone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000207	0.000727	CcSEcCtD
Hydrocodone—Headache—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000723	CcSEcCtD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000204	0.00583	CbGpPWpGaD
Hydrocodone—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000686	CcSEcCtD
Hydrocodone—OPRD1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000186	0.00531	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000181	0.00517	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000179	0.00511	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000179	0.00511	CbGpPWpGaD
Hydrocodone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000176	0.00502	CbGpPWpGaD
Hydrocodone—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00501	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000163	0.00466	CbGpPWpGaD
Hydrocodone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.0045	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000157	0.00448	CbGpPWpGaD
Hydrocodone—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000155	0.00444	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000153	0.00438	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000152	0.00435	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000151	0.00432	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000145	0.00414	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.000143	0.00407	CbGpPWpGaD
Hydrocodone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.00405	CbGpPWpGaD
Hydrocodone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.004	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00014	0.00399	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000138	0.00394	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000137	0.00391	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000134	0.00384	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000134	0.00382	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000132	0.00379	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00013	0.00373	CbGpPWpGaD
Hydrocodone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.00365	CbGpPWpGaD
Hydrocodone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00364	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000123	0.0035	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00012	0.00343	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00012	0.00342	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000118	0.00338	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000117	0.00333	CbGpPWpGaD
Hydrocodone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.00328	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000114	0.00327	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000114	0.00324	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000113	0.00323	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000112	0.00321	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000111	0.00317	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000111	0.00317	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.00011	0.00315	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000105	0.003	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000105	0.003	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000104	0.00298	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000104	0.00297	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000104	0.00296	CbGpPWpGaD
Hydrocodone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00294	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000102	0.00292	CbGpPWpGaD
Hydrocodone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.0029	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000101	0.0029	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	9.67e-05	0.00276	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	9.66e-05	0.00276	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.54e-05	0.00273	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.34e-05	0.00267	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	9.3e-05	0.00266	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.23e-05	0.00264	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	9.21e-05	0.00263	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.21e-05	0.00263	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	9.14e-05	0.00261	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	9.12e-05	0.00261	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.87e-05	0.00254	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.77e-05	0.00251	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.64e-05	0.00247	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	8.37e-05	0.00239	CbGpPWpGaD
Hydrocodone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.35e-05	0.00239	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	8.35e-05	0.00239	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	8.17e-05	0.00234	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	8.16e-05	0.00233	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.09e-05	0.00231	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8e-05	0.00228	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.79e-05	0.00223	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.79e-05	0.00223	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.72e-05	0.00221	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.68e-05	0.00219	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.4e-05	0.00211	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.35e-05	0.0021	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.26e-05	0.00207	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.16e-05	0.00204	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.07e-05	0.00202	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.06e-05	0.00202	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.99e-05	0.002	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	6.9e-05	0.00197	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.84e-05	0.00195	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.78e-05	0.00194	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.76e-05	0.00193	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.69e-05	0.00191	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.59e-05	0.00188	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.49e-05	0.00185	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.13e-05	0.00175	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.1e-05	0.00174	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.02e-05	0.00172	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.99e-05	0.00171	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.89e-05	0.00168	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.78e-05	0.00165	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.64e-05	0.00161	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.63e-05	0.00161	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.48e-05	0.00157	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.46e-05	0.00156	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.35e-05	0.00153	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.25e-05	0.0015	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.18e-05	0.00148	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.17e-05	0.00148	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.15e-05	0.00147	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.09e-05	0.00145	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.02e-05	0.00143	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.94e-05	0.00141	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.94e-05	0.00141	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.88e-05	0.0014	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.69e-05	0.00134	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.68e-05	0.00134	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.68e-05	0.00134	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.61e-05	0.00132	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.52e-05	0.00129	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.44e-05	0.00127	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.44e-05	0.00127	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.37e-05	0.00125	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.37e-05	0.00125	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.18e-05	0.00119	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.17e-05	0.00119	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.12e-05	0.00118	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.1e-05	0.00117	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.96e-05	0.00113	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.83e-05	0.00109	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.82e-05	0.00109	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.62e-05	0.00103	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.61e-05	0.00103	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.57e-05	0.00102	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.54e-05	0.00101	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.52e-05	0.00101	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.47e-05	0.000991	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.36e-05	0.00096	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.27e-05	0.000934	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.18e-05	0.00091	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.16e-05	0.000903	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.1e-05	0.000886	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.05e-05	0.000873	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.89e-05	0.000826	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.87e-05	0.000821	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.84e-05	0.000811	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.79e-05	0.000798	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.77e-05	0.000792	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.76e-05	0.00079	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.62e-05	0.000749	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.57e-05	0.000734	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.54e-05	0.000724	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.52e-05	0.00072	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.42e-05	0.000693	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.36e-05	0.000675	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.36e-05	0.000674	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.34e-05	0.000669	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.3e-05	0.000657	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.25e-05	0.000644	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.14e-05	0.000612	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.14e-05	0.000611	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.13e-05	0.000608	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.11e-05	0.000604	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.05e-05	0.000585	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.02e-05	0.000576	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.93e-05	0.00055	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.92e-05	0.000549	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.9e-05	0.000544	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.9e-05	0.000543	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.85e-05	0.000529	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.77e-05	0.000505	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.73e-05	0.000495	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.71e-05	0.000488	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.69e-05	0.000482	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.62e-05	0.000464	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.6e-05	0.000456	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.57e-05	0.000447	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.54e-05	0.000441	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.5e-05	0.000428	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.49e-05	0.000427	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.43e-05	0.000408	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.42e-05	0.000407	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.39e-05	0.000396	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.35e-05	0.000387	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.33e-05	0.000381	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.31e-05	0.000375	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.27e-05	0.000364	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.27e-05	0.000362	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.26e-05	0.000359	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.25e-05	0.000357	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.24e-05	0.000355	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.22e-05	0.00035	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.22e-05	0.000348	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.2e-05	0.000344	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000332	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.14e-05	0.000327	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.13e-05	0.000324	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.12e-05	0.000319	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.09e-05	0.000313	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.05e-05	0.0003	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.04e-05	0.000298	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.03e-05	0.000294	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.59e-06	0.000274	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.43e-06	0.00027	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.25e-06	0.000264	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.19e-06	0.000263	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.71e-06	0.000249	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.59e-06	0.000245	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.41e-06	0.00024	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8e-06	0.000229	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	7.89e-06	0.000225	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.77e-06	0.000222	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.59e-06	0.000217	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.54e-06	0.000216	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.11e-06	0.000203	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.16e-06	0.000147	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.93e-06	0.000141	CbGpPWpGaD
